The largest database of trusted experimental protocols

Human vegf165

Manufactured by Merck Group
Sourced in United States, United Kingdom

Human VEGF165 is a recombinant protein that represents the 165-amino acid isoform of Vascular Endothelial Growth Factor (VEGF). VEGF is a key regulator of angiogenesis and vascular permeability. This product can be used for cell culture, biochemical, and research applications.

Automatically generated - may contain errors

6 protocols using human vegf165

1

3D-Printed Vascularized Tissue Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
and reagents including NaOH, cefazolin, (3-aminopropyl) triethoxysilane (APTES), HUVEC culture media, BCA Protein Assay kit 23225, Human VEGF 165, fetal bovine serum (FBS), Geltrex matric, and PBS were purchased from Sigma-Aldrich (MO, USA). Polydimethylsiloxane (PDMS) was purchased from Dow (MI, USA). 3D-printing resins were obtained from Stratasys (MN, USA). Recombinant mouse VEGF (VEGF 164) was purchased from Biolegend (CA, USA) and anti-CD31 antibody (ab56299), anti-MMP9 antibody (ab38898), were purchased from Abcam (Cambridge, MA). gGoat antirat IgG (H+L) secondary antibody, Alexa Fluor 488, and goat antirabbit IgG (H+L) secondary antibody, Alexa Fluor 594 were purchased from Thermo Fisher Scientific (Waltham, MA).
+ Open protocol
+ Expand
2

Adenosine and VEGF Signaling in HUVECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVEC were serum-starved overnight in endothelial basal medium-2 (EBM-2; Lonza) with 0.5% FBS. Cells were then treated for one hour at 37 °C with adenosine (Sigma-Aldrich) and human VEGF165 (50 ng/mL; Sigma-Aldrich). Where indicated, bevacizumab (provided by Genentech) was added at a 10X molar ratio of VEGF during the 1-hour treatment period.
For inhibitor experiments, cells were pre-incubated for 30 minutes at 37 °C with non-selective adenosine receptor antagonist CGS-15943 (1 μM; Tocris Bioscience) or ENT1 inhibitor S-(4-Nitrobenzyl)-6-thioinosine (NBTI, 1 μM; Sigma-Aldrich). Inhibitors were added at the same concentrations during the 1-hour treatment period.
+ Open protocol
+ Expand
3

Evaluating DARC in Retinal Angiogenesis Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
A pilot study was also performed on three New Zealand White rabbits to assess DARC using an established model of retinal angiogenesis [21 ]. All experiments were designed and conducted in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and under protocols approved by the UK. Home Office. Briefly, 2.5 kg rabbits were anesthetized with 50 mg/kg intramuscular injection of ketamine hydrochloride and 10 mg/kg xylazine, respectively. Pupils were dilated with 2.5% phenylephrine and 1% tropicamide. 50 ul containing 1 ug of humanVEGF165 (Sigma, UK) dissolved in 0.1% bovine serum albumin (Sigma UK) was injected intravitreally into the left eye only of each animal. Forty-eight hours later, under general anesthesia, rabbits received intravenous Anx776 (0.2 mg) and 1% sodium fluorescein and underwent DARC and 448 imaging at 40 min using high-resolution ICGA and FFA modes of the HRA-Spectralis. Three masked observers performed manual counts on DARC images.
+ Open protocol
+ Expand
4

Quantifying Aflibercept Binding to VEGF

Check if the same lab product or an alternative is used in the 5 most similar protocols
96-well ELISA plates (Corning-Costar) were coated with 0.2 µg/ml human VEGF165 (Sigma-Aldrich) diluted in PBS (Sigma-Aldrich). After overnight incubation at 4 °C, plates were blocked with PBS containing 4% skimmed milk (S) (Sigma-Aldrich) for 1 hour at room temperature and washed 4 times with PBS containing 0.05% Tween-20 (T) (Sigma-Aldrich). Serial dilutions of collected aflibercept samples (1000.0–0.5 ng/ml) in PBS/S/T were added to the plates followed by incubation at room temperature for 1.5 hours. Plates were then washed as described above, before an alkaline phosphatase-conjugated goat polyclonal antibody directed towards human IgG Fc (Sigma-Aldrich), diluted (1:5000) in PBS/S/T, was added and incubated at room temperature for 1.5 hours. The plates were washed as above before 100 µl of the p-nitrophenylphospate substrate (Sigma-Aldrich), diluted to 10 µg/ml in diethanolamine buffer, was added. The absorbance was measured at 405 nm using a Sunrise spectrophotometer (TECAN).
+ Open protocol
+ Expand
5

Surface Plasmon Resonance Binding Analysis of Aflibercept to VEGF

Check if the same lab product or an alternative is used in the 5 most similar protocols
SPR was performed using a Biacore T200 instrument (GE Healthcare) with CM5 sensor chips coupled with human VEGF165 (Sigma-Aldrich) (~300 resonance units (RU)) using amine-coupling chemistry as described by the manufacturer. Briefly, the coupling was performed by injecting 5 μg/ml of VEGF diluted in 10 mM sodium acetate, pH 4.5 (GE Healthcare) using the amine-coupling kit (GE Healthcare). HBS-EP pH 7.4 buffer (0.01 M HEPES, 0.15 NaCl, 3 mM EDTA 0.005% surfactant P20) was used as both dilution and running buffer. Binding analysis was performed by injecting 100 nM of each aflibercept sample over the immobilized surface using a flow rate of 50 µl/min and 10 mM NaOH was used to regenerate the CM5 surface. The sample compartment was kept at 4 °C while the binding analysis was performed at 25 °C. The binding data were zero adjusted and the maximum binding responses of the individual injections were normalized using the BIAevaluation software version 4.1.
+ Open protocol
+ Expand
6

Aflibercept-FcRn Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
96-well ELISA plates (Costar) were coated with 0.5 µg/ml human VEGF165 (Sigma-Aldrich) and blocked before serial dilutions of collected aflibercept samples were added as above. Plates were washed with PBS/T (pH 7.4) or 67 mM phosphate buffer (pH 5.5), before 1.0 µg/ml of GST-tagged receptor FcRn35 (link), diluted in pH 7.4 or pH 5.5 buffer, was added and incubated at room temperature for 1.5 hours. The plates were washed as above before a horseradish peroxidase-conjugated goat polyclonal antibody directed towards GST (Rockland Immunochemicals Inc), diluted (1:8000) in pH 7.4 or pH 5.5 buffer, was added and incubated at room temperature for 1.5 hours. After washing as above, bound receptor was detected using the tetramethylbenzidine substrate (Calbiochem) and the reaction was stopped by adding 50 µl 1 M HCl. The absorbance was measured at 450 nm using a Sunrise spectrophotometer (TECAN).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!